Knowing the Future
A sophisticated sovereign wealth fund with major global holdings selected GroveStreet as its partner in venture stage technology.
GroveStreet’s Solution:
GroveStreet built and cultivates a core pool of venture relationships covering TMT and life sciences including established and emerging teams in the US, Europe, and Asia.
The platform is designed to provide early identification of segments that can provide attractive returns and that may disrupt the investor’s existing holdings.
We collaborate with the investor’s in-house industry teams which span private and public markets to identify direct deal opportunities with a view to scaled follow-on investments at IPO and beyond.
Since 2012, GroveStreet has been entrusted with $700 million plus associated direct investments held in a separate pool.